Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Hims & Hers Expands Weight Loss Offering, Adds Lilly’s Zepbound to Platform
In This Article:
Hims & Hers Health said it is expanding its weight-loss offerings with the addition of Eli Lilly & Co. Zepbound and generic liraglutide. The telehealth-consultation platform on Tuesday said it aimed to bring its customers more treatment options to best suit their needs. “We’ve now expanded that choice even further by adding access to generic liraglutide and branded tirzepatide through our platform,” the company said.
Terms and Privacy Policy